Iter Investments

Iter Investments is a venture capital firm headquartered in Fort Lauderdale, Florida, focusing on early-stage companies within the psychedelic industry. Established in 2021 by Dustin Robinson and Robert Velarde, the firm aims to transform the mental and behavioral health sector by supporting innovative companies leveraging psychedelics for therapeutic purposes. Iter Investments raised over $20 million for its inaugural fund, which it uses to back ventures across the psychedelic value chain, from drug development and clinics to technology and digital therapeutics. The firm’s portfolio includes companies like Psilera, Beckley Psytech, and Awakn Life Sciences, which work on developing treatments for conditions such as depression, PTSD, and addiction. Iter also invests in supporting infrastructure, such as Psygen, a supplier of psychedelic ingredients, and Tripp, which integrates virtual reality with psychedelic science for therapeutic applications. Furthermore, they have established Nucleus, a holding company for media and data assets, to help expand their reach across the industry ecosystem. The team at Iter consists of experts across law, science, and healthcare, ensuring robust due diligence and strategic support for their portfolio companies. By leading funding rounds and taking board seats, Iter Investments provides not only capital but also guidance to navigate the complex regulatory and commercial landscape. Their holistic approach aims to bridge the gap between groundbreaking research and widespread commercialization, ensuring that advancements in psychedelic therapies can effectively reach the market.